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During their productive cycle, herpesviruses exhibit a strictly regulated temporal cascade
of gene expression that can be divided into three general stages: immediate-early (IE),
early (E), and late (L). This expression program is the result of a complex interplay
between viral and cellular factors at both the transcriptional and post-transcriptional
levels, as well as structural differences within the promoter architecture for each of the
three gene classes. Since the cellular enzyme RNA polymerase II (RNAP-II) is responsible
for the transcription of herpesvirus genes, most viral promoters contain DNA motifs that
are common with those of cellular genes, although promoter complexity decreases from
immediate-early to late genes. Immediate-early and early promoters contain numerous
cellular and viral cis-regulating sequences upstream of a TATA box, whereas late
promoters differ significantly in that they lack cis-acting sequences upstream of the
transcription start site (TSS). Moreover, in the case of the β- and γ-herpesviruses, a
TATT box motif is frequently found in the position where the consensus TATA box of
eukaryotic promoters usually localizes. The mechanisms of transcriptional regulation
of the late viral gene promoters appear to be different between α-herpesviruses and
the two other herpesvirus subfamilies (β and γ). In this review, we will compare the
mechanisms of late gene transcriptional regulation between HSV-1, for which the viral
IE transcription factors – especially ICP4 – play an essential role, and the two other
subfamilies of herpesviruses, with a particular emphasis on EBV, which has recently
been found to code for its own specific TATT-binding protein.
Keywords: herpesviruses, Epstein-Barr virus, PIC, late gene, TBP-like, viral gene expression
INTRODUCTION
Herpesviridae form a large family of enveloped double-stranded DNA viruses with large and
complex genomes ranging from 120 to 250 kbp in length. Herpesviruses have long co-evolutionary
histories with their natural hosts. The consequences of this co-evolution are a wide virus incidence
in the natural host populations and infections leading to virus persistence in specific cell types.
Occasional reactivation from infected cells allows these viruses to maintain a dynamic infectious
reservoir for transmission of infectious virions to new naïve hosts. Herpesviruses are categorized
into three sub-families according to their cellular tropism, pathogenicity, and behavior under
culture conditions in the laboratory. α-herpesviruses establish latency in neurons; they have a rapid
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replication cycle and can infect a broad variety of species in
experimental animal systems as well as a wide range of cells
in vitro. β-herpesviruses establish latency in macrophages and
lymphocytes and γ-herpesviruses in lymphocytes. Both β- and
γ-herpesviruses replicate more slowly and in a more restricted
range of cells than α-herpesviruses. Members of each of the
three sub-families of herpesviruses have been described to cause
characteristic diseases in humans (Table 1). The ability of
herpesviruses to establish a latent state of infection with low levels
of viral gene expression, for the life of the host, is a defining
feature of these pathogens.
The herpesvirus cycle is characterized by two distinct phases:
latency and the productive or lytic cycle. During latency, no
active viral production occurs and a very limited number of viral
genes are expressed. Under appropriate stimuli, the herpesvirus
productive cycle is activated leading to the genesis of new virions.
A temporally regulated cascade of gene expression – during
which three distinct kinetic classes of transcripts are expressed
in a sequential manner – characterizes the viral productive cycle
(Figure 1). It should be noted that the great majority of viral
genes are expressed during the productive cycle and that all
protein-coding genes are transcribed by cellular RNA polymerase
II (RNAP-II) (Costanzo et al., 1977).
The productive cycle starts with the expression of the
immediate-early (also refers to as IE or α) genes characterized by
their ability to be transcribed in the absence of de novo protein
synthesis. These genes encode for viral regulatory proteins
involved in transcriptional control of the early (also refers to as
E or β) genes. The products of the viral early genes are required
for (i) the subsequent replication of the viral genome; (ii) the
expression of the late (also refers to as L or γ) viral genes; and
(iii) the cytoplasmic accumulation of some of the early and late
viral mRNAs. For viral DNA amplification, herpesviruses encode
their own DNA replication machinery as well as a number of
enzymes that contribute to the biosynthesis of deoxynucleoside
triphosphates. In addition, it has been shown in the case of the
TABLE 1 | Human herpesvirus (HHV) classification.
Subfamily Name Synonym Genome
length
Primary target
cell
Pathophysiology Site of
latency
Means of spread
α HHV-1 Herpes simplex
virus-1 (HSV-1)
135 472 bp Mucoepithelial Oral and genital herpes, as well
as other herpes simplex infections
(gingivostomatitis, keratitis, and
dermal whitlows, encephalitis).
Neuron Close contact (oral
or sexually
transmitted
infection)
HHV-2 Herpes simplex
virus-2 (HSV-2)
154 746 bp Mucoepithelial Neuron Close contact (oral
or sexually
transmitted
disease)
HHV-3 Varicella zoster
virus (VZV)
124 884 bp Mucoepithelial Chickenpox and shingles Neuron Respiratory and
close contact
β HHV-5 Cytomegalovirus
(hCMV)
229 354 bp Monocyte,
lymphocyte, and
epithelial cells
Congenital cytomegalovirus
infection (when symptomatic)
causes hepatosplenomegaly,
retinitis, rash, and central nervous
system involvement.
Infectious mononucleosis-like
syndrome.
Immunocompromised hosts may
develop life-threatening
disseminated disease involving
the lungs, gastrointestinal tract,
liver, retina, and central nervous
system.
Monocyte,
lymphocyte
Saliva, urine, milk
HHV-6A
HHV-6B
Roseolovirus,
Herpes
lymphotropic virus
159 321 bp T cells Associated with exanthem
subitem (roseola) and with
rejection of transplanted kidneys.
T cells Close contact
(saliva) or
respiratory
HHV-7 144 861 bp T cells T cells
γ HHV-4 Epstein-Barr virus
(EBV)
171 823 bp B cells and
epithelial cells
Causative agent for Infectious
mononucleosis.
Associated with: Burkitt’s
lymphoma, Hodgkin diseases
post-transplant
lymphoproliferative syndrome,
nasopharyngeal carcinoma, a
subtype of gastric carcinoma.
B cells Close contact
(saliva),
transfusions, tissue
transplant
HHV-8 Kaposi’s sarcoma-
associated
herpesvirus (KSHV)
138 146 bp Lymphocyte and
other cells
Kaposi’s sarcoma, primary
effusion lymphoma, some types
of multicentric Castleman’s
disease
B cells Close contact
(sexual), saliva
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FIGURE 1 | Schematic representation of herpesvirus productive cycle.
The productive cycle begins with the expression of the immediate-early
genes: The immediate early genes present on the viral genome are
transcribed to mRNA and then translated into proteins. These products are
transcription factors required for activation of the early genes. These genes
are also transcribed from the viral genome. The products of early genes are
involved in (i) the formation of the viral DNA replication complex, (ii) the
composition of the viral transcription complex responsible for expression of
the β- and γ-herpesvirus late viral genes, (iii) the cytoplasmic accumulation of
a subset of early and late viral mRNAs. Following amplification of the viral
genome by the viral DNA replication complex, the late viral genes are
expressed probably from the newly replicated viral DNA. Most of the late gene
products contribute to the formation of the viral particle. The four stages
(immediate-early, early, DNA replication and late) of the viral productive cycle
are indicated in the right part of the scheme. The detailed steps of the
productive cycle are indicated in the left part of the scheme.
α-herpesvirus, HSV-1, that the function of several early genes is
to turn off the synthesis of the immediate early gene products and
to induce the expression of the late genes (Honess and Roizman,
1974, 1975). In general, expression of HSV-1 early genes is not
dependent on viral DNA replication. However, the continued
accumulation of a subset of early genes – called early late or β2 –
is enhanced by the onset of viral DNA replication.
Following viral DNA replication, late (L or γ) viral genes –
that mainly encode structural proteins – start to be transcribed,
ultimately leading to the assembly and release of infectious
particles. The late genes are subdivided into two classes (γ1 and
γ2) based on their apparent requirement for DNA replication.
Expression of the γ1 genes is delayed compared to that of the
early genes. By contrast, expression of the γ2 genes appears
to be strictly dependent upon the onset or completion of lytic
DNA amplification. Their expression is neither observed in the
presence of inhibitory concentrations of drugs that block viral
DNA synthesis nor with viruses carrying conditional mutations
in some of the early genes at the non-permissive temperature.
How the immediate-early and early genes are regulated is
now quite well defined, whereas the mechanisms involved in
transcriptional regulation of the late viral genes have been
much less characterized. A central question concerning the
regulation of viral gene expression is the nature of cis-acting
sequences and viral trans-acting signals, which permit the cellular
transcriptional machinery to differentiate between immediate
early, early, and late genes. Moreover, although it has been
long known that late viral gene transcription is tightly coupled
to viral DNA replication, the underlying mechanism is poorly
understood, especially for the β- and γ-herpesviruses. This review
will focus on recent studies that have started to unravel some
of the mechanisms involved in β- and γ-herpesviruses late gene
transcription.
DEPENDENCE UPON VIRAL DNA
REPLICATION
For all DNA viruses, it is well known that viral gene expression is
temporally regulated during productive infection and is generally
divided into early and late phases separated by viral genome
replication. For the herpesviruses, according to the model initially
based on the study of HSV-1, late gene expression is strictly
dependent on the lytic viral DNA replication (Honess and
Roizman, 1974; Stinski, 1978; Mavromara-Nazos and Roizman,
1987). An identical model has been proposed for EBV and
MHV-68 on the basis of experiments using inhibitors of the
viral DNA polymerase, such as phosphonoacetic acid (PAA;
Summers and Klein, 1976; Datta and Hood, 1981; Martinez-
Guzman et al., 2003). Treatment of EBV-infected cells by PAA
not only blocks viral lytic DNA replication, but also expression
of the late EBV genes (Serio et al., 1997). This model is supported
by the observation that the Raji cell line – which carries a mutated
EBV genome with a deletion in the single-stranded DNA-binding
protein gene – is defective for both lytic viral DNA replication
and late gene expression. Thus, viral DNA replication appears
to constitute an important temporal boundary between early and
late gene expression in all herpesviruses.
Interestingly, when HSV-1 late viral promoters are removed
from their viral context and introduced into either plasmid
vectors or the host genome, they no longer display the
characteristics of late viral promoters (Dennis and Smiley, 1984;
Silver and Roizman, 1985; Wade et al., 1992; Wade and Spector,
1994; Chang and Ganem, 2000). One possible explanation for the
need for viral DNA replication in the viral context, is that non-
replicated viral genomes cannot serve as templates for late gene
expression, even if all viral trans-acting factors are expressed via
a separate viral genome replicated in trans (Mavromara-Nazos
and Roizman, 1987). This hypothesis is supported by the fact
that once a lytic origin of replication is provided in cis to a late
promoter on a plasmid vector, proper late gene regulation can
be observed in infected cells (Johnson and Everett, 1986a; Amon
et al., 2004). Taken together, these experiments suggest that the
induction of the HSV-1 γ2 genes is mediated by a cis-acting
function associated with viral DNA synthesis. Thus the viral
origin of DNA replication (OriLyt) is a critical cis-acting element
regulating replication-dependent induction of herpesvirus late
promoters.
Cis-ACTING ELEMENTS
Viral gene expression is largely regulated at the transcriptional
level, genes being transcribed by cellular RNAP-II (Godowski
and Knipe, 1986; Weinheimer and McKnight, 1987). In order
to define the cis-acting elements required for the expression
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of late viral genes, the promoter regions of several late genes
from different herpesviruses were cloned upstream of a reporter
gene. The activity of these promoters – or sets of promoter
deletion mutants – was then assessed following transfection of
the various constructs into infected cells. Up to now, few late
viral promoters have been studied in such detail, but in all cases
examined the same type of simplistic promoter structure has
been revealed: a sequence comprised between positions −30 and
+30 relative to the transcription start site (TSS), including a
TATA box motif, appears to be the only important sequence
allowing typical late gene regulation of transcription (Johnson
and Everett, 1986b; Shapira et al., 1987; Chang et al., 1998; Serio
et al., 1998; Tang et al., 2004). This absence of cis-acting elements
in late viral promoters is in sharp contrast with what is known
for cellular or viral immediate-early and early gene promoters
(Figure 2).
In the case of the HSV-1 gC late gene, a study by Homa et al.
(1988) identified a 15 bp sequence surrounding the TATA box as
being sufficient for this particular late viral gene’s transcription.
For the sake of simplicity, such a minimal sequence, including
a TATA box motif, will be hereafter referred to as the TATA
element. Interestingly, replacement of the gC sequence by the
TATA element from an early viral gene promoter resulted in a
transcriptionally inactive gC gene. However, if the substitution
was made using another late gene TATA element, the gC gene was
transcribed normally.
FIGURE 2 | Schematic representation of typical immediate-early, early and late gene promoters. These examples come from EBV and HSV-1. pBZLF1 is
the promoter of the EBV immediate-early gene encoding the viral transcription factor called EB1, BZLF1, or Zta. pICP4 is the promoter of the HSV-1 immediate-early
gene encoding the viral transcription factor called ICP4. The negative cis-regulatory elements are indicated in red. The positive cis-regulatory elements are labeled in
green. pBHRF1 is the promoter of the EBV early gene encoding the BHRF1 protein. EB1 and R are the viral transcription factors responsible for the activation of
early gene expression. pTK is the promoter of the HSV-1 early gene encoding the Thymidine Kinase protein. pBcLF1 is the promoter of the EBV late BcLF1 gene that
encodes the major capsid protein. pgC is the promoter of the HSV-1 late gene encoding the glycoprotein C. The viral late promoters do not contain any positive or
negative cis-regulatory elements. In addition to the TATA box element, HSV-1 late promoters contain an initiator element (inr). By contrast to HSV-1, EBV late
promoters contain a TATT box at the place of the canonical TATA box. IE, immediate early; E, early; L, late.
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Comparison of TATA elements from several early and late
HSV-1 genes did not reveal any obvious differences to account
for one sequence functioning as a late promoter and another
not. A chimeric HSV-1 gene construct that contained the distal
regulatory elements of the early TK gene, fused upstream of the
TATA element from the late gC gene, exhibited both early and
late kinetics of gene expression. This study indicates that late
gene expression requires the presence of a TATA element in the
promoter but no further upstream sequences, whereas cis-acting
regulatory elements are required for early gene expression (Homa
et al., 1988).
An interesting case concerns the hCMV UL44 gene that
encodes the double-stranded DNA-binding protein. The UL44
transcription unit initiates at three distinct sites that are
separated by around 50 nucleotides and are differentially
regulated during productive infection. Two of these start
sites (the distal and proximal) are used at early times,
whereas the middle start site is used only at late times.
Moreover, expression from the late start site is dependent
upon viral DNA synthesis. Interestingly, the UL44 early viral
promoters have canonical TATA sequences (TATAA), whereas
the late viral promoter displays a non-canonical TATA sequence
(TATTATTA). Mutations in this TATTATTA motif, significantly
affect the level of late viral gene expression, attesting to the
importance of the motif (Chang et al., 1989; Leach and Mocarski,
1989; Isomura et al., 2007). Moreover, replacement of the distal
canonical TATA box by the non-canonical TATTATTA sequence
induced the expression of an alternative transcript at late times
after infection, indicating that the non-canonical TATA box
directs expression of the gene at late times of infection (Isomura
et al., 2008).
The region responsible for conferring late gene regulation in
the case of the EBV BcLF1 gene (encoding the major capsid
protein), also contains a TATA box variant (TATTAAA; Serio
et al., 1998). The presence of this type of non-canonical TATA
box sequence in EBV late promoters appears to be one of the
determinants of late promoter activity and most of the EBV late
promoters display this unusual TATT motif (Figure 3). This
also appears to be the case for KSHV and MHV68 (Wong-Ho
et al., 2014). Replacement of the T at the fourth position of the
TATT box by an A, led to a complete loss of late gene expression
specificity (Serio et al., 1998; Gruffat et al., 2012), although this
is not absolute (Amon et al., 2004). It is interesting to note that
some of the early genes also contain a non-canonical TATT box,
suggesting that the sequence of the box by itself is not sufficient
to determine the timing of the expression of the gene.
Thus, the TATA box - or its TATT variant - appears to be the
major control element required to determine the transcription
initiation site, the strength of transcription and the timing of
expression, of the late viral genes.
Trans-ACTING ELEMENTS
From recent data, it is clear that a strong difference exists
between α-herpesviruses and β- or γ-herpesviruses in terms of
the viral proteins required for the expression of the late viral
FIGURE 3 | TATA box sequence conservation of early and late EBV
genes presented by sequence logo. For each position, the percentage of
occurrence of each DNA base is indicated.
genes. This difference may reflect the variation observed in the
type of TATA-box sequence used to control the expression of
the late genes: a TATA-box for the α-herpesviruses vs. a TATT-
box for the β- and γ-herpesviruses. Transcriptional activation
of α-herpesvirus late genes requires immediate-early proteins,
especially the ICP4 transcription factor. By contrast, the β- and
γ-herpesvirus immediate-early proteins are dispensable for late
gene expression, but these viruses encode specific early proteins
that trans-activate the late genes through the TATT-box.
α-HERPESVIRUSES
Transcription initiation is a major control point for both viral
and cellular gene expression and requires the proper assembly
of the general cellular transcription factors TFIIA, TFIIB, TFIID,
TFIIE, TFIIF, and TFIIH, as well as RNAP-II to form pre-
initiation complexes (PIC) on core promoter elements. PIC
formation begins with the binding of the general transcription
factor TFIID, a multi-subunit complex composed of the TATA-
binding protein (TBP) together with around 14 TBP-associated
factors (TAFs). Although TBP is sufficient for basal transcription
initiation, activated transcription requires the TAFs (Buratowski,
1994). Many cellular and viral transcription factors have been
shown to interact with the general transcription machinery. TAFs
also play an important role in the recognition of non-TATA
box core promoter elements such as INRs (initiator elements)
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that can be present in place of – or in addition to – a TATA
box on core promoters (Juven-Gershon et al., 2008). TFIID
binding to the TATA box and/or to an INR is stabilized by TFIIA
and TFIIB. Whereas TFIIB is essential for basal transcription
directed by either TBP or TFIID, TFIIA is dispensable for
TBP-directed basal transcription, although it can stabilize TBP
interaction with the TATA box (Lee et al., 1992). The formation
of a TFIID-TFIIA-TFIIB-DNA complex allows the subsequent
recruitment of the other general transcription factors, TFIIE,
TFIIF, TFIIH, and RNAP-II. These are recruited individually,
or as preformed complexes, to the core promoters, completing
the PIC assembly, which is then ready to initiate transcription.
The recruitment of TFIID and the general transcription factors
is crucial for the regulation of both early and late viral gene
transcription. Hence, the efficiency of the formation of the PIC
on the viral promoters is a critical step in determining the rate
of transcription. Promoter recognition and binding by TFIID, as
well as PIC formation, are enhanced by the action of activator
proteins. One well-studied viral trans-activator, the VP16 protein
from HSV-1, activates viral immediate-early gene expression. Its
acidic activation domain is assumed to enhance the formation
of the PIC by interacting with TFIIB. Thus, VP16 does not
facilitate TFIID binding to the TATA box, but rather enhances
TFIIB binding to the complex, which then promotes RNAP-II
recruitment. In addition, VP16 interacts with TFIIA and this
interaction also facilitates PIC assembly (Kobayashi et al., 1995,
1998).
Infected-cell polypeptide 4 (ICP4) is one of the five IE proteins
of HSV-1. ICP4 (Figure 4A) is a regulator of viral transcription
required for the efficient transcription of both early and late
viral genes (Watson and Clements, 1980; Everett, 1984; DeLuca
and Schaffer, 1985; O’Hare and Hayward, 1985a; Godowski and
Knipe, 1986; Sampath and DeLuca, 2007). ICP4 increases the
transcription rates of several viral genes (Godowski and Knipe,
1986), but also represses the transcription of certain others
(Everett, 1984; DeLuca and Schaffer, 1985; O’Hare and Hayward,
1985a,b; Godowski and Knipe, 1986). ICP4 does not appear
to require any specific binding sites to activate transcription,
(Everett, 1984; Coen et al., 1986). By contrast, the binding of
ICP4 to specific sites has been shown to be involved in repression,
as in the case of the LAT gene promoter (Freeman and Powell,
1982; Faber and Wilcox, 1986; Roberts et al., 1988; Gu et al.,
1995).
In the case of HSV-1, initiator elements (INRs) which overlap
the initiation start site, have been found to be important, in
addition to the TATA box, for late gene regulation (Steffy and
Weir, 1991; Guzowski and Wagner, 1993; Guzowski et al., 1994).
INRs are common to many cellular core promoters and can
promote transcription initiation in the absence of a TATA box.
However, there are also examples where INRs can synergize
with a TATA box (reviewed in reference Smale and Kadonaga,
2003). These elements are specifically recognized by components
of the general transcription factor TFIID (Kaufmann et al.,
1998). The INR is the only necessary element, in addition to
the TATA box, for efficient activation of the late promoters by
ICP4. In an in vitro-reconstituted transcription system, ICP4
absolutely requires cis-acting factors to activate transcription
FIGURE 4 | Transcriptional regulation of α-herpesviruses late gene
expression. (A) Schematic representation of the initial step of formation of
the Pre-Initiation Complex (PIC) on early and late α-herpesvirus promoters. (a)
Early promoters contain either a TATA box, an initiator element (Inr) or both,
associated with different cis-regulatory elements (cis-RE). TFIID (TBP
associated with the TAFs) is stabilized on the promoter via its interaction with
TFIIA. The structure of the viral chromatin is probably modified by the
cis-regulatory factors to allow formation of the PIC and recruitment of ICP4.
(b) Late promoters are composed of a TATA box associated with an Inr. The
expression level of TFIIA is reduced within cells during the productive cycle.
Recruitment of TFIID onto the late viral promoters is stabilized by ICP4.
(B) Schematic representation of ICP4 functional domains. Gray boxes and
text describe the various domains of ICP4 and their function. The functional
domains of ICP4 include two transcriptional regulatory regions localized in the
N- and C-terminal parts of the protein, respectively, separated by a region
carrying a dimerization domain, a DNA-binding domain with a helix-turn-helix
motif, and a nuclear localization sequence (NLS).
from a representative early promoter. In the case of the late viral
promoters, ICP4 appears to stabilize the formation of the PIC
via enhancement of TFIID’s binding to the promoter (Carrozza
and DeLuca, 1996; Grondin and DeLuca, 2000). Moreover, there
is a differential requirement for general transcription factors
between the early and late gene promoters: TFIIA is required
for efficient ICP4 activation of the early TK promoter but is
dispensable for ICP4 activation of the late gC promoter (Gu
and DeLuca, 1994; Carrozza and DeLuca, 1998; Zabierowski
and DeLuca, 2004). The dispensability of TFIIA for activation
of this promoter by ICP4 is dependent on an intact INR.
Interestingly, it has been shown that during the infection process
and the viral productive cycle, the expression of TFIIA decreases
dramatically (Zabierowski and DeLuca, 2004). Taken together,
these observations suggest that, in the case of the regulation
of late viral gene expression, ICP4 can substitute for TFIIA
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by stabilizing TFIID, but only when the promoter contains a
functional INR. In the case of early promoters, ICP4 facilitates
the ability of TFIIA to stabilize the binding of TBP to the TATA
box.
Moreover, ICP4 co-purifies with a subset of TAFs (TAF-3,
TAF-4, TAF-5, TAF-6, and TAF-9), suggesting that ICP4 can
stably associate with different types of the TFIID complex formed
at different times post-infection on the early and late viral genes
in infected cells (Lester and DeLuca, 2011). The TAF-1 amino-
terminal domain contains a negative regulatory element that
inhibits TBP-TATA complex formation. TFIIA has been shown
to competitively de-repress the inhibitory effect of TAF-1 by
destabilizing the interactions between TAF-1 and TBP (Ozer
et al., 1998). By interacting with TAF-1, ICP4 may function
in a manner analogous to TFIIA in that it may alleviate the
inhibitory effects of TAF-1 (Figure 4A). Two transactivation
domains that cooperate to activate viral gene expression have
been mapped in ICP4, one in the N-terminal and the other in
the C-terminal of the protein (Figure 4B). A mutant of ICP4
lacking the C-terminal activation domain efficiently activates
many early genes, whereas late genes are poorly activated and
virus growth is severely impaired (DeLuca and Schaffer, 1987;
Wagner et al., 2012b). Interestingly, the N-terminal regulatory
domain of ICP4 is involved in the ICP4-TBP interaction (Wagner
et al., 2012a), while interaction with TAF-1 is dependent on an
intact ICP4 C-terminal domain (Carrozza and DeLuca, 1996;
Brown et al., 1999; Wagner et al., 2012a). The N-terminal region
of ICP4 interacts with TBP to stabilize its interaction with the
TATA box in the context of TFIID. This may explain why
ICP4 differentially affects early and late promoter regulation
(Figure 4B).
In addition to ICP4, it has been shown that regulation of
the late viral gene, gC, requires the viral ICP27 protein (Jean
et al., 2001). ICP27 is an immediate-early protein essential for
virus production. It is conserved among all herpesviruses and
is implicated in the cytoplasmic accumulation of some early
and late viral mRNAs transcribed from intronless genes (Sandri-
Goldin and Mendoza, 1992; Juillard et al., 2012). However, the
ability of ICP27 to promote late gene expression appears to be
distinct from its function in mRNA export. In this case, the effect
is apparently at the mRNA transcription level and could be linked
to the finding that ICP27 interacts directly with the C-terminal
domain of RNAP-II.
In addition to its role in viral DNA amplification, the viral
early protein ICP8 – a single stranded DNA-binding protein –
is thought to play a role in viral late gene expression. In effect,
in cells expressing a dominant negative form of ICP8, both late
protein synthesis and the accumulation of late gC mRNA are
reduced during HSV-1 infection (Godowski and Knipe, 1986;
Gao and Knipe, 1991; Chen and Knipe, 1996). However, it is
difficult to conclude since late gene expression is dependent on
viral DNA replication.
Viral DNA replication per se is known to be important for
late viral gene expression. However, more direct contribution
by the replication complex in late gene transcription, could be
envisaged. In this context, an interaction between ICP8 – which
is part of the viral DNA replication complex – and RNAP-II
has been reported (Zhou and Knipe, 2002; Olesky et al., 2005).
This interaction requires ICP27, ICP22, UL13, and US3 kinase
(Bastian and Rice, 2009).
β- AND γ-HERPESVIRUSES
The question of how β- and γ-herpesvirus late gene expression
is regulated remained unsolved for a long time, until the group
of R. Sun identified several viral proteins from MHV68 (Murine
HerpesVirus-68) that were required for late gene expression.
Using a library of signature-tagged mutant MHV-68 viruses,
Sun’s group identified 41 viral genes essential for completion
of the virus life cycle (Song et al., 2005). Among these, were
identified five viral genes (ORF18, ORF24, ORF30, ORF31,
and ORF34) whose deletion resulted in a loss of late viral
gene transcription, but with no effect on either early viral
gene expression or viral DNA-replication (Jia et al., 2004;
Arumugaswami et al., 2006; Wu et al., 2009; Gong et al.,
2014). However, nothing was known about the function of these
proteins, nor the way in which they could potentially cooperate to
direct late gene expression. In particular, whether these proteins
could interact with late gene promoters was unknown. Similar
studies carried out with the β-herpesvirus, hCMV, showed that
UL79, UL87, UL91, UL92, and UL95 (the analogs of MHV68
ORF18, ORF24, ORF30, ORF31, and ORF34, respectively) are
also essential for late gene transcription (Isomura et al., 2011;
Chapa et al., 2013; Omoto and Mocarski, 2013, 2014). EBV
also encodes analogs of these MHV68 and hCMV proteins:
BVLF1, BcRF1, BDLF3.5, BDLF4, and BGLF3, respectively.
Interestingly, these genes, classified as early genes and well
conserved in both the β- and γ-herpesviruses do not appear
to have analogs in α-herpesviruses. A comparative survey of
the productive cycle genes of various herpesviruses revealed
that only seven of the viral genes that are conserved in both
the β- (hCMV and HHV6) and γ- (EBV, KSHV, and MHV68)
herpesvirus subfamilies are absent from HSV-1 (Table 2). Hence,
two additional proteins – called BTRF1 and BFRF2 in the
case of EBV – could potentially be involved in the specific β-
and γ-herpesvirus late gene expression. However, the analog of
BTRF1 in MHV68 (ORF23) was previously shown to be the
product of a late gene and dispensable for virus production,
both in cell culture and in vivo. By contrast, we recently
demonstrated that BFRF2 is absolutely required for EBV late
gene expression (Aubry et al., 2014). In addition, we showed
that the six EBV early gene products – BVLF1, BcRF1, BDLF3.5,
BDLF4, BGLF3, and BFRF2 – form a complex necessary and
sufficient for the activation of a late gene reporter in EBV-negative
cells.
Interestingly, an in silico study identified structural homology
between one of these genes, BcRF1, and TBP from the
thermophilic archaea Pyrococcus woesei. Similar structural
homology could also be identified with the analog hCMV protein,
UL87. Although overall sequence identity is very low (around
10%), a saddle-like fold characteristic of the TBP structure as well
as the presence of important residues known to be involved in
the-protein-DNA interface, mark both proteins as being distantly
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TABLE 2 | Homologous genes involved in late gene expression between
beta and gamma-herpesviruses.
γ-herpesviruses β-herpesviruses
Virus EBV KSHV MHV68 CMV HHV6
Gene name BcRF1
(TBP-like)
ORF24 ORF24 UL87 U58
BFRF2 ORF66 ORF66 UL49 U33
BGLF3 ORF34 ORF34 UL95 U67
BVLF1 ORF18 ORF18 UL79 U52
BDLF4 ORF31 ORF31 UL92 U63
BDLF3.5 ORF30 ORF30 UL91 U62
related to TBP (Wyrwicz and Rychlewski, 2007). Accordingly,
BcRF1 specifically interacts with the TATT sequence present
on EBV late gene promoters (Gruffat et al., 2012). In addition
to the EBV BcRF1 protein, the MHV-68 analog, ORF24, has
recently been shown to specifically interact with the TATT
box of MHV-68 late gene promoters (Wong-Ho et al., 2014),
thus confirming the DNA-binding properties of this family of
herpesvirus proteins. To date, few TBP-like proteins have been
identified in eukaryotic cells, and BcRF1 and its analogs in other
β- and γ-herpesviruses are the first TBP-like proteins to have
been characterized from a virus, with the exception of giant
viruses.
In addition to the discovery of a role for BcRF1 and its
analogs, as TATT-binding proteins, a putative function has
been assigned to the hCMV UL79 protein – the EBV BVLF1
analog – as a transcription elongation factor not required for
the recruitment of RNAP-II onto the viral late promoters (Perng
et al., 2014). UL79 co-purifies with UL87, UL95, UL49, and the
hCMV DNA polymerase proteins UL112/113. In the absence
of UL79, RNAP-II remains on the promoter and accumulates
because it does not elongate RNA efficiently. The carboxy-
terminal domain (CTD) of RNAP-II is composed of 52 repeats
of the heptapeptide Y-S-P-T-S-P-S, whose phosphorylation is
tightly regulated. RNAP-II is recruited unphosphorylated onto
the promoter by the PIC, then released from the PIC following
phosphorylation of S5 and S7 by cdk7 (TFIIH). During
transcription elongation, RNAP-II CTD is fully phosphorylated
whereas at the termination step, only S2 remains phosphorylated.
Finally, RNAP-II dissociates from the DNA template in an
unphosphorylated form (Eick and Geyer, 2013). UL79 is not
involved in the phosphorylation of RNAP-II CTD at the S2 or S5
positions, suggesting that pUL79 is essential for a transcription
step downstream of the initiation of elongation and before
its termination, probably destabilizing a negative elongation
factor.
Except for the two factors mentioned above, no function has
yet been assigned to the other proteins involved in late viral
transcription. However, we now know that none of these proteins
is able to activate the expression of a late reporter gene in a
transient transfection assay, but they can activate when they are
expressed together. Furthermore, they appear to interact together
to form a complex (Aubry et al., 2014; Watanabe et al., 2015).
In addition, at least EBV BcRF1, MHV-68 ORF30 and ORF34,
and hCMV UL95 and UL91 and KSHV ORF24 are critical for
recruiting RNAP-II to the late viral promoters (Wu et al., 2009;
Aubry et al., 2014; Davis et al., 2015). The formation of a large
protein complex containing a TBP-like protein and able to recruit
RNAP-II onto the core promoters of the late viral genes strongly
suggests that the ß- and γ-herpesviruses encode for their own PIC
responsible for the induction of late genes. By analogy with the
cellular PIC formed around TBP, we have proposed to call this
complex vPIC for viral PIC.
As discussed above, the full set of the six EBV proteins is
required in order to induce the expression of a reporter gene
under the control of a late promoter (Aubry et al., 2014).
Interestingly, although the proteins from the different β- and
γ-herpesviruses are well conserved, so far it has not been
possible to exchange a particular EBV protein for its hCMV
counterpart (Aubry et al., 2014). However, this appears to be
possible between human and mouse CMV proteins, presumably
because the two viruses are very close to each other in terms
of evolution (Chapa et al., 2013). Nevertheless, the hCMV
complex as a whole can induce EBV late gene expression
(Aubry et al., 2014). This suggests that although the components
of the complex have evolved differently, there is a strong
functional conservation of the vPIC between the different β- and
γ-herpesviruses.
How vPIC regulates late viral gene expression is not clear,
but BcRF1 has been shown to interact with the TATT element
of the viral late promoters in order to initiate transcription
(Gruffat et al., 2012). This suggests that BcRF1 is at the origin
of the complex’s formation on the viral late promoters. However,
in vitro, BcRF1 binds in an undifferentiated way to both TATA
and TATT motifs. Thus, how this protein discriminates between
early and late promoters in vivo is not yet understood. One
possible explanation could be that the association of BcRF1 with
other components of the vPIC may favor a specific recognition
of late gene promoters. In this context, the BFRF2 protein could
play such a role. BFRF2 consists of two domains: a variable
N-terminal part and a C-terminus well-conserved between β- and
γ-herpesviruses. This latter domain contains several conserved
cysteine residues, which could potentially form a zinc-finger
protein. Although the detailed activity of BFRF2 needs to be
further explored, it is possible that this protein could be directly
involved in binding to DNA.
The six viral proteins required for the formation of the
vPIC represent the minimal set of viral proteins necessary
for the activation of the late viral genes. Additional accessory
viral factors and cellular proteins might be required for the
complete formation of vPIC, similarly to what is known for
the viral DNA replication complex. In effect, herpesviruses
encode seven proteins absolutely required for viral DNA
replication (Table 3; Fixman et al., 1992, 1995), but additional
accessory proteins are necessary to obtain a fully efficient
replication complex. Accordingly, it has recently been shown
that the EBV protein kinase, BGLF4 – analogous to KSHV
and MHV68 ORF36 and hCMV UL97 proteins – which
localizes to the replication compartments, participates in late
gene transcriptional regulation. Abolishing expression of BGLF4
had no significant effect on either early gene expression or
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TABLE 3 | Herpesviruses replication proteins.
Virus HSV-1 EBV CMV Function
Gene name UL30 BALF5 UL54 DNA polymerase (POL)
UL42 BMRF1 UL44 Polymerase
processivity factor
(PPF)
UL29 BALF2 UL57 Single-stranded
DNA-binding protein
(SSB)
UL5 BBLF4 UL105 Helicase (HEL)
UL52 BSLF1 UL70 Primase (PRI)
UL8 BBLF2/3 UL102 Primase associated
factor (PAF)
UL9∗ BZLF1∗ – Origin-binding protein
(OBP)
∗HSV-1 UL9 and EBV BZLF1 are both origin-binding proteins, but they share no
homology in terms of sequence.
viral DNA replication, but significantly reduced the amount of
virus released (Gershburg et al., 2007; Feederle et al., 2009; El-
Guindy et al., 2014). Moreover, analysis of the EBV transcriptome
revealed that the expression of 31 late genes was reduced in the
absence of BGLF4. How BGLF4 controls late gene expression is
however, unknown. No direct interaction between BGLF4 and
vPIC components has as yet been documented, but it has been
shown that the kinase activity of BGLF4 is necessary for optimal
expression of the late genes, suggesting that post-translational
modifications of some of the vPIC proteins could be important
for their activity.
As far as cellular factors are concerned, several proteins
interacting with some MHV68 vPIC components have now
been identified (Lee et al., 2011). For example, TAX1BP1 (Tax1-
binding protein) and PCBP1 [Poly(rC)-binding protein 1, also
referred to as αCPs or hnRNP E] have been found to interact
with ORF31 and ORF34, respectively, in a yeast two-hybrid
screen. Modification of expression of either of these cellular
proteins has significant – although opposite – effect on MHV-
68 production. Whereas inhibiting TAX1BP1 expression reduces
MHV-68 late gene expression, silencing PCBP1 increases it (Lee
et al., 2011).
In the case of EBV, the cellular factor TSG101 (Tumor
Susceptibility Gene 101) which is a component of the ESCRT1
(endosomal sorting complexes required for transport 1),
implicated in different cellular functions including cytokinesis,
protein ubiquitination, transcriptional regulation, cell cycle
regulation and proliferation, as well as viral budding, was
found to modulate the expression level of EBV late genes. In
effect, upon virus reactivation, the level of several EBV late
transcripts is markedly reduced in cells lacking TSG101. The
underlying mechanism was found to be Rta-related (Chua et al.,
2007).
Taken together, these studies strongly suggest that β- and
γ-herpesviruses share a similar mechanism to regulate their late
gene expression. The vPIC components that have been identified
are probably functionally equivalent to the complex formed
between some of the cellular PIC components and ICP4 in the
case of α-herpesviruses.
LINK BETWEEN VIRAL DNA
REPLICATION AND vPIC FUNCTION
We have seen that the β- and γ-herpesvirus vPICs specifically
stimulate the promoters of late viral genes. However, late gene
expression not only depends on these virally encoded trans-acting
factors but also on the accomplishment of viral DNA replication
(Aubry et al., 2014). Several hypotheses have been proposed to
explain this dependency: (i) DNA replication may stimulate late
viral transcription because it increases the copy number of the
viral genomes. Accordingly, some studies have shown that the
increase in RNA transcription is proportional to the level of
DNA amplification. This suggests that template amplification
is a key determinant of the RNA transcription rate (Johnson
et al., 1986). These results are consistent with a straightforward
amplification model, whereby replication generates additional
templates available for transcription; (ii) DNA amplification may
allow titration of a putative repressor, and scanning of the DNA
by the replication complex could alter the balance of positive- and
negative-acting factors associated with the late viral promoters;
(iii) proteins stably associated with the viral replication complex
could have a dual role, one that is specific for the replication of
the viral DNA, and a second by which they enhance transcription
of viral late promoters when brought into their proximity; (iv)
since DNA-replication occurs at nuclear sites localized near PML
domains (Bell et al., 2000) it is possible that this location favors
transcription from late promoters; (v) viral DNA replication may
be important because it initiates the formation of replication
factories in which late gene transcription would be favored; (vi)
viral DNA replication may lead to the genesis of viral genomes
with a structure different from that of non-replicated genomes
that allows better access for the transcription machinery to the
late gene promoters. The two last hypotheses appear at present to
be the more realistic and will be developed further.
Replication Factories
Cellular DNA replication occurs in microscopically visible
structures (called replication factories) at discrete sites in the
nucleus. These factories consist of DNA associated with the
replication machinery that can be detected through their co-
localization with the DNA clamp protein, PCNA (Proliferating
Cell Nuclear Antigen). Thousands of these factories form in the
nuclei during S phase (Leonhardt et al., 2000). They accumulate
in early S phase, give rise to punctuate peri-nuclear structures in
mid-S phase, and then start to decrease in number toward the end
of S phase.
During latency, γ-herpesviruses are dependent on the cellular
replication machinery and the replication of the viral episomes
probably takes place in cellular replication factories. However,
during the productive cycle, all herpesviruses amplify their
DNA from a specific origin of replication – called OriS for
HSV-1 and OriLyt for EBV (Hammerschmidt and Sugden,
1988) – using their own replication machinery. This viral DNA
replication takes place in discrete sites in nuclei, called viral
DNA replication compartments. With the progression of viral
DNA replication, these compartments enlarge and fuse with
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FIGURE 5 | Transcriptional regulation of β- and γ-herpesviruses late gene expression. (A) Overview of EBV productive cycle. The viral immediate-early and
early genes are transcribed from the episomic viral DNA and their expression controlled by the cellular transcription machinery formed around the cellular PIC.
Expression of the late viral genes is dependent upon viral DNA replication and on the presence of the viral specific Pre-Initiation Complex (vPIC) composed of five
viral proteins associated with the viral TATT-box binding protein like (TBP-L). (B) Expression of the late viral genes is linked to newly replicated DNA. vPIC alone can
activate the expression of a late gene present on a plasmid during a transient transfection assay (a), but it is not able to induce the expression of a late viral gene
present on a stable episome (b). The chromatinized DNA bearing the OriLyt origin of DNA replication can be replicated by the viral DNA replication complex (c). In
these conditions, vPIC, present in the replication factories, can activate expression of the late viral genes (d). The link between the replication complex and vPIC is
not proven but several arguments described in the main text strongly argue in favor of such a model. IE, immediate-early; E, early; L, late; OBP, origin-binding
protein; He, helicase; Pol, polymerase; ssDBP, single-strand DNA-binding protein; Pr, primase: P-A, primase associated: PP, Polymerase processivity; TBP-L,
TATA-binding protein like; Bc, BcRF1; F2, BFRF2; G3, BGLF3; V1, BVLF1; D4, BDLF4; D3.5, BDLF3.5.
one another to form large globular structures that eventually
almost completely fill the nucleus at the later stages. Cellular
chromatin is then tightly compacted and localized to the
periphery of the nucleus (Monier et al., 2000; Chiu et al.,
2013). It has recently been shown that even though the viral
DNA replication complex mediates unlicensed replication of
viral DNA, genome amplification is often delayed until the
early S phase of the ensuing cell cycle. It is not clear how
herpesvirus replication factories form, but similar to the cellular
replication factories, they can be marked by PCNA staining,
although the PCNA stays at the periphery of these structures
(Daikoku et al., 2005; Chiu et al., 2013). Accordingly, PCNA
is probably not required for viral DNA amplification since the
virus encodes its own DNA clamp factor (BMRF1 in the case
of EBV; Tsurumi et al., 1993). Analysis of the architecture of
the viral replication compartments has revealed that BMRF1 is
enriched in core structures which form specific domains inside
the replication compartment (Sugimoto et al., 2011). BMRF1
forms a heterodimer with the EBV BALF5 polymerase catalytic
subunit (Tsurumi et al., 1993) but also forms head-to-head
Frontiers in Microbiology | www.frontiersin.org 10 June 2016 | Volume 7 | Article 869
fmicb-07-00869 June 2, 2016 Time: 12:15 # 11
Gruffat et al. Herpesvirus Late Gene Expression
homodimers or tetrameric ring structures (Murayama et al.,
2009; Nakayama et al., 2010) that presumably contribute to the
BMRF1-related core structures. The BMRF1 protein is also a
polymerase processivity factor and may thus play a dual role
during lytic replication: one assisting the viral polymerase during
elongation and the other protecting the viral genome after
synthesis. In effect, although de novo synthesis of viral DNA
occurs mainly outside of the BMRF1 cores, replicated DNA is
subsequently stored inside BMRF1 core structures (Sugimoto
et al., 2011, 2013). Thus, viral DNA amplification and viral
genome maturation appears to be, respectively, assigned to the
outside and the inside of the BMRF1 cores. Using confocal laser
scanning microscopy and 3D surface reconstruction imaging,
Sugimoto et al have recently shown that viral early mRNAs
are mainly found outside the BMRF1 cores whereas the viral
late mRNAs are located inside (Sugimoto et al., 2013). In
accordance with this observation, these authors found that the
viral BcRF1 protein – the TBP-like EBV vPIC component – is
localized inside BMRF1 cores, suggesting that viral late gene
transcription takes place within these particular structures. These
results indicate that there is a spatial relationship between
the sites of viral late gene transcription and viral DNA
replication.
Similarly, the UL87, UL95, and UL79 proteins from hCMV
assemble with the viral genome into micro-foci containing the
early viral protein UL44, which is structurally homologous to the
EBV BMRF1 protein (Perng et al., 2011). As proposed for EBV,
the recruitment of the UL44 protein together with UL79, UL87,
and UL95, into the replication foci, provides an appropriate
environment for late gene transcription. However, no direct
interaction between UL44 and components of the hCMV vPIC
has yet been described. This is also the case for the EBV proteins.
Consequently, although it is still not known whether vPIC is
recruited into the amplification core structure by the viral DNA
replication machinery, a tight connection certainly exists between
these two complexes.
Viral Chromatin Modification
The herpesvirus genome is maintained in host cells in an
episomic state, covered by nucleosomes and carrying substantial
epigenetic marks. Epigenetic regulation has been found to
be important for viral gene expression (Cuevas-Bennett and
Shenk, 2008; Bergbauer et al., 2010; Kalla et al., 2010; Chen
et al., 2013; Lieberman, 2013). During the productive cycle,
the viral replication complex amplifies viral DNA. As discussed
above, the function of cellular PCNA – which is excluded from
the replication factories (Chiu et al., 2013) – is not directly
required for this. PCNA is known to recruit the cellular DNA
methyl-transferase that performs CpG methylation of the newly
synthesized DNA during the course of replication. Because of
the exclusion of PCNA from the replication factories, cellular
DNA methyl-transferase cannot be recruited onto the newly
replicated DNA, leading to the genesis of viral genomic DNA
deprived of methylation marks. This is in sharp contrast to
the heavily methylated pattern associated with the viral genome
during latency. However, it is important to note that treatment of
cells by inhibitors of DNA methyl-transferase is not sufficient to
induce synthesis of late EBV genes in Raji or HH514 cells (Szyf
et al., 1985; Fronko et al., 1989). In addition to its interaction
with the cellular DNA methyl-transferase, PCNA also interacts
with the Chromatin Assembly Factor 1 (CAF-1). CAF-1 is a
histone chaperone for the tetrameric formation and deposition
of histones (H3-H4)2, and is found on replicating DNA directly
behind the replicative helicase (Shibahara and Stillman, 1999).
In the absence of PCNA, CAF-1 is not recruited onto replicated
DNA and consequently, the newly synthesized viral DNA is not
covered by histones. The newly synthesized viral DNA therefore
appears to be devoid of chromatin structure in the replication
factories. Finally, it has been shown that histones are excluded
from the viral DNA replication foci during the productive cycle
(Chiu et al., 2013). Such presumably “naked” DNA would be fully
accessible to transcription factors provided they are present in the
same structures (Figure 5). The hypothesis that viral late genes
are transcribed by the vPIC from “naked” and unmethylated
DNA is reinforced by the finding that vPIC alone is not able to
induce expression of a late viral gene when it is present in an
episome stably maintained in cells, whereas it can activate the
expression of a late gene present on a plasmid during a transient
transfection assay (Serio et al., 1997; Amon et al., 2004; Aubry
et al., 2014).
CONCLUSION/FUTURE DIRECTIONS
For a successful infection, DNA viruses require the coordinated
expression of immediate-early, early and late genes. Immediate-
early gene products are responsible for stimulating early gene
expression, whose products are responsible for both viral DNA
replication and late gene expression. Although not yet well
understood, the mechanisms underlying late gene expression
appear to differ greatly between various DNA viruses. In the
case of simian virus 40, for example, the amplification of
viral DNA is required in trans to attenuate the repression of
viral late promoters (Wiley et al., 1993) and the viral large
T antigen plays an essential role in activating the promoters
(Keller and Alwine, 1984). In the case of adenoviruses, viral
DNA replication facilitates late gene expression directly or
indirectly by promoting the expression of viral trans-acting
factors, or by the recruitment of cellular transcription factors
to late promoters (Thomas and Mathews, 1980; Iftode and
Flint, 2004; Morris and Leppard, 2009). For papillomaviruses,
late gene expression is tightly associated with keratinocyte
differentiation and is mediated in part by alternative mRNA
splicing (Jia et al., 2009). The majority of eukaryotic DNA viruses,
including α-herpesviruses, use a host-cell-derived transcription
machinery to express their genes. However, some DNA viruses
like baculoviruses or the T7 bacteriophage encode a viral-
specific transcription complex, including a viral-encoded RNA-
polymerase, necessary for expression of their late genes. The
requirement for a specific viral RNA polymerase is probably due
to the special structure of these late viral promoters. In effect,
to promote late viral gene expression, viral RNA polymerases
recognize unique promoter elements that are absent from cellular
gene promoters. For instance, baculovirus RNA polymerase
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recognizes a TAAG element in the late and very late promoters,
whereas T7 RNA polymerase exhibits a binding affinity to a 23-bp
consensus sequence found on T7 bacteriophage late promoters.
Among herpesviruses, α-herpesviruses have evolved differently
to β- and γ-herpesviruses, in the mechanisms they use to express
their late genes. Only β- and γ-herpesviruses encode a specific
vPIC formed around a viral TBP-like protein recruited onto a
TATT box motif that constitutes the only cis-regulatory element
of their late gene promoters. The requirement for a specific
viral TBP-like protein is important because cellular TBP is not
very efficient in binding a TATT sequence. Accordingly, very
few cellular gene promoters contain such a TATT-box. This is a
marked similarity with baculoviruses and T7 bacteriophage for
which late viral gene promoter structure differs from that of both
early viral and cellular genes.
Although many aspects of herpesvirus replication and gene
expression have recently been elucidated, the contribution of
viral DNA replication to the process of viral late gene expression
remains to be elucidated. Moreover, further studies will be
needed to understand the role of each component of the β- and
γ-herpesvirus vPIC in transcription initiation and elongation.
Elucidation of the structure of the different vPIC components and
extensive mutational analysis of these factors should facilitate the
identification of their functional domains and mode of action. In
addition, the comparative analysis of vPICs identified in different
β- and γ-herpesviruses should help in the definition of the specific
function of each vPIC component.
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